Bioorganic and Medicinal Chemistry Letters 1998-Jan
New taxanes as highly efficient reversal agents for multidrug resistance in cancer cells.
Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
Keywords
Abstract
New non-cytotoxic taxanes synthesized from 10-deacetylbaccatin III and special hydrophobic acylating agents show remarkable MDR reversal activity (< or = 99.8%) against drug-resistant human breast cancer cells when co-administered with paclitaxel or doxorubicin. This activity is ascribed to the highly efficient blocking of P-glycoprotein efflux by these new taxanes.